Erythropoiesis-stimulating agents in the treatment of cancer-associated anemia.
Kara
Ozgur
O
Dizdar
Omer
O
Altundag
Kadri
K
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D000068256:Darbepoetin alfa; D004921:Erythropoietin / Q000009:adverse effects* / Q000031:analogs & derivatives; D006397:Hematinics / Q000009:adverse effects*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D011994:Recombinant Proteins; D012306:Risk; D054556:Venous Thromboembolism / Q000453:epidemiology* / Q000209:etiology*
D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068256:Darbepoetin alfa